Evidence map›Paper›PMID 15688026›Full record

ArticleOncogene2005

Cooperation and selectivity of the two Grb2 binding sites of p52Shc in T-cell antigen receptor signaling to Ras family GTPases and Myc-dependent survival.

Laura Patrussi, Maria Teresa Savino, Michela Pellegrini, Silvia Rossi Paccani, Enrica Migliaccio, Simon Plyte, Luisa Lanfrancone, Pier Giuseppe Pelicci, Cosima T Baldari

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The adaptor protein Shc plays a key role during early B cell development.Journal of immunology (Baltimore, Md. : 1950) · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Laura PatrussiDepartment of Evolutionary Biology, University of Siena, Via Aldo Moro 2, Siena 53100, Italy.
Maria Teresa Savino
Michela Pellegrini
Silvia Rossi Paccani
Enrica Migliaccio
Simon Plyte
Luisa Lanfrancone
Pier Giuseppe Pelicci
Cosima T Baldari
University of Siena · ITRipamonti · ITEuropean Institute of Oncology · ITPfizer (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shc proteins participate in a variety of processes regulating cell proliferation, survival and apoptosis. The two ubiquitously expressed isoforms, p52Shc/p46Shc, couple tyrosine kinase receptors to Ras by recruiting Grb2/Sos complexes to a membrane-proximal localization. Tyrosine residues 239/240 and 317 become phosphorylated following receptor engagement and, as such, form two Grb2 binding sites, which have been proposed to be differentially coupled to Myc-dependent survival and to fos-dependent proliferation, respectively. Here, we have addressed the individual function of YY239/240 and Y317 in T-cell antigen receptor (TCR) signaling. We show that p52Shc is phosphorylated on both YY239/240 and Y317 following TCR engagement. Mutation of either YY239/240 or Y317 results in impaired interaction with Grb2 and inhibition of Ras/MAP kinase activation and CD69 induction, supporting a role for both Grb2 binding sites in this function. Substitution of either YY239/240 or Y317 also results in a defective activation of Rac and the coupled stress kinases JNK and p38. Furthermore, mutation of Y317 or, to a larger extent, of YY239/240, results in increased activation-induced cell death, which in cells expressing the FF239/240 mutant is accompanied by impaired TCR-dependent c-myc transcription. The data underline a pleiotropic and nonredundant role of Shc, mediated by both YY239/240 and Y317, in T-cell activation and survival.

Indexed as

Genes, mycAdaptor Proteins, Signal TransducingBinding SitesCell SurvivalCloning, MolecularGRB2 Adaptor ProteinHumansJurkat CellsMicroscopy, ConfocalMutagenesisras GTPase-Activating ProteinsReceptors, Antigen, T-CellRecombinant ProteinsReverse Transcriptase Polymerase Chain ReactionShc Signaling Adaptor ProteinsSignal TransductionAdaptor Proteins, Signal TransducingGRB2 Adaptor ProteinGRB2 protein, humanras GTPase-Activating ProteinsReceptors, Antigen, T-CellRecombinant ProteinsSHC1 protein, humanShc Signaling Adaptor ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1

Identifiers

PMID15688026
OpenAlexW2085760543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.